$ITOC

iTonic Holdings (ITOC) has regained compliance with Nasdaq's minimum bid price requirement, maintaining a closing bid price of at least $1.00 per share for ten consecutive days. The company received a deficiency notice in 2025 and was granted an extension to October 19. iTonic implemented a 16-for-1 share consolidation on October 6. The company focuses on digital medical technologies and AI investments in healthcare.

iTonic Holdings Ltd (ITOC) will execute a 16-for-1 reverse stock split on Oct 6, 2026, to meet Nasdaq's minimum bid price requirement, pending approval. The company aims to avoid delisting due to prolonged low stock price.

iTonic Holdings Ltd (Nasdaq: ITOC) announced a 16-for-1 share consolidation, reducing its Class A and B shares from 109,382,000 and 7,668,000 to 6,836,375 and 479,250, respectively. The consolidation, effective October 6, 2026, aims to boost the share price to meet Nasdaq's $1.00 minimum bid requirement. The company has until October 19, 2026, to comply.